Reloxin: Better than Botox?

Botox vs. Reloxin

As expected, the FDA has recently approved Reloxin®, which is priced 15% lower than Botox®. How will it affect the industry? With the current economic situation and everyone on tight budget, Reloxin® – chemically the same as Botox® – may be a good alternative for people who want to maintain the results achieved via Botox®, but at a cheaper price point.

You may have seen or read a lot more about Botox® recently. Rumor has it that Allergan has been ramping up their PR efforts online in order to prepare for their inevitable competition. So what’s the difference between the two?

Botox® VS Reloxin®
There are small differences between the two, but the essentially work the same way. Both relax the muscles, which in turn causes wrinkles to diminish. The effects of Botox® typically last anywhere between 3-6 months, and the makers of Reloxin® are claiming that results last a little longer with little or no side effects. Another plus of Reloxin® being FDA approved is that the lower price point may in turn drive down the cost of Botox®, which will certainly be beneficial for everyone.

It is still too early though. Botox has a 20 year proven track record, so it may not be prudent to change in order to save a few dollars. We will have to wait between six to 12 months to see how good it is. One thing for sure is that Reloxin® – the new kid on the block – is getting a lot of attention and the makers of Botox® will definitely be looking over their shoulder the next few months.

Photo source: http://kosmetologia.com.pl/zdjecia/wiadomosci/marzec2009/1028452_syringes_and_vial.jpg

Tags: Botox, cosmetic surgery, Cosmetic Treatments, Dr. David Schlessinger, FDA, FDA Approval, Fraxel, injectable, IPL, laser, Reloxin, Schlessinger Eye & Face

This entry was posted on Thursday, May 21st, 2009 at 6:04 pm and is filed under Cosmetic Treatments. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.